WW vs. NVO

Last updated Apr 2, 2026

Compare and contrast key facts about WW International, Inc. (WW) and Novo Nordisk A/S (NVO).

Performance

WW vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WW International, Inc. (WW) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

WW vs. NVO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
WW WW International, Inc.	-51.87%	2,200.39%	-85.49%	126.68%	-76.07%	-33.89%	-36.14%	-0.88%	-12.94%	286.72%
NVO Novo Nordisk A/S	-25.80%	-39.22%	-15.93%	54.84%	22.66%	63.52%	23.33%	28.70%	-12.98%	52.92%

Fundamentals

Market Cap WW : $140.43M NVO : $162.26B
EPS WW : $18.36 NVO : $22.15
PE Ratio WW : 0.77 NVO : 1.65
PS Ratio WW : 1.16 NVO : 0.55
PB Ratio WW : 0.44 NVO : 0.84
Total Revenue (TTM) WW : $695.95M NVO : $297.20B
Gross Profit (TTM) WW : $501.59M NVO : $240.66B
EBITDA (TTM) WW : $1.18B NVO : $153.18B

Returns By Period

In the year-to-date period, WW achieves a -51.87% return, which is significantly lower than NVO's -25.80% return. Over the past 10 years, WW has underperformed NVO with an annualized return of -0.25%, while NVO has yielded a comparatively higher 5.04% annualized return.

WW

• 1D: 2.33%
• 1M: -35.50%
• YTD: -51.87%
• 6M: -45.76%
• 1Y: 2,471.79%
• 3Y*: 50.56%
• 5Y*: -15.06%
• 10Y*: -0.25%

NVO

• 1D: -0.73%
• 1M: -0.01%
• YTD: -25.80%
• 6M: -36.19%
• 1Y: -43.88%
• 3Y*: -20.88%
• 5Y*: 3.69%
• 10Y*: 5.04%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

WW vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WW

WW Risk / Return Rank: 90
WW Sharpe Ratio Rank: 49
WW Sortino Ratio Rank: 100
WW Omega Ratio Rank: 100
WW Calmar Ratio Rank: 99
WW Martin Ratio Rank: 99

NVO

NVO Risk / Return Rank: 10
NVO Sharpe Ratio Rank: 8
NVO Sortino Ratio Rank: 11
NVO Omega Ratio Rank: 10
NVO Calmar Ratio Rank: 11
NVO Martin Ratio Rank: 11

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WW vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WW International, Inc. (WW) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WW	NVO	Difference
Sharpe ratio Return per unit of total volatility	0.24	-0.81	+1.06
Sortino ratio Return per unit of downside risk	170.24	-0.99	+171.23
Omega ratio Gain probability vs. loss probability	26.29	0.86	+25.43
Calmar ratio Return relative to maximum drawdown	18.33	-0.82	+19.15
Martin ratio Return relative to average drawdown	37.05	-1.41	+38.46
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WW vs. NVO - Sharpe Ratio Comparison

The current WW Sharpe Ratio is 0.24, which is higher than the NVO Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of WW and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WW	NVO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.24	-0.81	+1.06
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.00	0.10	-0.10
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.00	0.16	-0.16
Sharpe Ratio (All Time) Calculated using the full available price history	-0.00	0.46	-0.46

Correlation

The correlation between WW and NVO is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WW vs. NVO - Dividend Comparison

WW has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 4.94%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
WW WW International, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NVO Novo Nordisk A/S	4.94%	3.31%	1.68%	1.00%	1.20%	1.35%	1.87%	2.14%	1.45%	1.52%	2.87%	0.92%

Drawdowns

WW vs. NVO - Drawdown Comparison

The maximum WW drawdown since its inception was -99.87%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for WW and NVO.

Drawdown Indicators

	WW	NVO	Difference
Max Drawdown Largest peak-to-trough decline	-99.87%	-74.70%	-25.17%
Max Drawdown (1Y) Largest decline over 1 year	-76.21%	-55.03%	-21.18%
Max Drawdown (5Y) Largest decline over 5 years	-99.68%	-74.70%	-24.98%
Max Drawdown (10Y) Largest decline over 10 years	-99.87%	-74.70%	-25.17%
Current Drawdown Current decline from peak	-86.36%	-73.49%	-12.87%
Average Drawdown Average peak-to-trough decline	-51.09%	-17.56%	-33.53%
Ulcer Index Depth and duration of drawdowns from previous peaks	42.15%	31.83%	+10.32%

Volatility

WW vs. NVO - Volatility Comparison

WW International, Inc. (WW) has a higher volatility of 22.58% compared to Novo Nordisk A/S (NVO) at 9.39%. This indicates that WW's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WW	NVO	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.58%	9.39%	+13.19%
Volatility (6M) Calculated over the trailing 6-month period	59.54%	38.79%	+20.75%
Volatility (1Y) Calculated over the trailing 1-year period	17,085.05%	54.16%	+17,030.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	7,233.51%	37.82%	+7,195.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	5,076.77%	32.28%	+5,044.49%

Financials

WW vs. NVO - Profitability Comparison

The chart below illustrates the profitability comparison between WW International, Inc. and Novo Nordisk A/S over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

WW - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, WW International, Inc. reported a gross profit of 114.10M and revenue of 161.45M. Therefore, the gross margin over that period was 70.7%.

NVO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Novo Nordisk A/S reported a gross profit of 54.38B and revenue of 67.28B. Therefore, the gross margin over that period was 80.8%.

WW - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, WW International, Inc. reported an operating income of -12.94M and revenue of 161.45M, resulting in an operating margin of -8.0%.

NVO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Novo Nordisk A/S reported an operating income of 27.12B and revenue of 67.28B, resulting in an operating margin of 40.3%.

WW - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, WW International, Inc. reported a net income of -5.83M and revenue of 161.45M, resulting in a net margin of -3.6%.

NVO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Novo Nordisk A/S reported a net income of 22.96B and revenue of 67.28B, resulting in a net margin of 34.1%.